Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 10:41 AM ET

Date/Time Source News Release
04/22/2025 08:00 AM EDT Business Wire Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
04/21/2025 08:00 AM EDT Business Wire Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)
03/10/2025 04:05 PM EDT Business Wire Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
03/05/2025 08:00 AM EST Business Wire Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025
02/11/2025 08:00 AM EST Business Wire Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
02/04/2025 08:00 AM EST Business Wire Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference
01/27/2025 04:05 PM EST Business Wire Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering
01/06/2025 08:00 AM EST Business Wire Lineage Cell Therapeutics Issues Letter to Stockholders
11/21/2024 05:00 PM EST Business Wire Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
11/20/2024 08:00 AM EST Business Wire Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
Page